Showing results (1431-1440 of 5,686) with videos related to
Sort By:
Pageof 569
Drug Design, Development and Therapy|June 9, 2016
Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injuryYanzhe Wang, Zhiyi He, Shumin DengDrug Design, Development and Therapy|June 9, 2016
Electroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administrationSzilvia Berkó, Kálmán F Szűcs, Boglárka Balázs, et al.Drug Design, Development and Therapy|May 25, 2016
Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1Zhiguo Liu, Shufang Yu, Di Chen, et al.Drug Design, Development and Therapy|May 25, 2016
Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseasesSaqib Uzma, Mirza S BaigDrug Design, Development and Therapy|May 25, 2016
Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in ratsHao Zhou, Dan Xi, Jichen Liu, et al.Drug Design, Development and Therapy|August 1, 2015
Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimensChen Yang, Ying Liu, Wen-qi Xi, et al.Drug Design, Development and Therapy|August 1, 2015
Mechanisms underlying probucol-induced hERG-channel deficiencyYuan-Qi Shi, Cai-Chuan Yan, Xiao Zhang, et al.Drug Design, Development and Therapy|August 1, 2015
Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo studyHeba F Salem, Sayed M Ahmed, Ashraf E Hassaballah, et al.Drug Design, Development and Therapy|August 1, 2015
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysisShuai Miao, Shi-Yao Zhou, Chun-Shan Han, et al.Drug Design, Development and Therapy|August 1, 2015
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agentsRajappan Revathi, Ramachandran Venkatesha Perumal, Karkala Sreedhara Ranganath Pai, et al.Pageof 569